Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 2356 AL 2370

Guam dementia syndrome revisited in 2011

Lee SE.

Curr Opin Neurol. 2011 Dec;24(6):517-24. doi: 10.1097/WCO.0b013e32834cd50a.

Bladder dysfunction and parkinsonism: current pathophysiological understanding and management strategies

Campeau L, Soler R, Andersson KE.

Curr Urol Rep. 2011 Dec;12(6):396-403. doi: 10.1007/s11934-011-0219-8.

[Progressive nonfluent aphasia]

Murayama S, Saito Y.

Brain Nerve. 2011 Oct;63(10):1037-46.

Systematic review of parkinsonian syndromes in short- and long-term survivors of paraquat poisoning

Brent J, Schaeffer TH.

J Occup Environ Med. 2011 Nov;53(11):1332-6. doi: 10.1097/JOM.0b013e318233775d.

Combined STN/SNr-DBS for the treatment of refractory gait disturbances in Parkinson's disease: study protocol for a randomized controlled trial

Weiss D, Wächter T, Meisner C, Fritz M, Gharabaghi A, Plewnia C, Breit S, Krüger R.

Trials. 2011 Oct 11;12:222. doi: 10.1186/1745-6215-12-222.

Toward automated, at-home assessment of mobility among patients with Parkinson disease, using a body-worn accelerometer

Weiss A, Sharifi S, Plotnik M, van Vugt JP, Giladi N, Hausdorff JM.

Neurorehabil Neural Repair. 2011 Nov-Dec;25(9):810-8. doi: 10.1177/1545968311424869.

Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers

Brockmann K, Gröger A, Di Santo A, Liepelt I, Schulte C, Klose U, Maetzler W, Hauser AK, Hilker R, Gomez-Mancilla B, Berg D, Gasser T.

Mov Disord. 2011 Nov;26(13):2335-42. doi: 10.1002/mds.23991. Epub 2011 Oct 11.

Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature

Mahmoud F, Tampi RR.

Am J Geriatr Pharmacother. 2011 Dec;9(6):405-12. doi: 10.1016/j.amjopharm.2011.09.002. Epub 2011 Oct 10.

The yin and yang of amyloid: insights from α-synuclein and repeat domain of Pmel17

McGlinchey RP, Yap TL, Lee JC.

Phys Chem Chem Phys. 2011 Dec 7;13(45):20066-75. doi: 10.1039/c1cp21376h. Epub 2011 Oct 12.

Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials

Freed CR, Zhou W, Breeze RE.

Neurotherapeutics. 2011 Oct;8(4):549-61. doi: 10.1007/s13311-011-0082-9.

Preservation of function in Parkinson's disease: what's learning got to do with it?

Beeler JA.

Brain Res. 2011 Nov 14;1423:96-113. doi: 10.1016/j.brainres.2011.09.040. Epub 2011 Sep 29.

CSF α-synuclein concentrations do not fluctuate over hours and are not correlated to amyloid β in humans

Spies PE, Slats D, Rikkert MG, Tseng J, Claassen JA, Verbeek MM.

Neurosci Lett. 2011 Oct 31;504(3):336-8. doi: 10.1016/j.neulet.2011.09.063. Epub 2011 Oct 4.

Six questions on the subthalamic nucleus: lessons from animal models and from stimulated patients

Baunez C, Yelnik J, Mallet L.

Neuroscience. 2011 Dec 15;198:193-204. doi: 10.1016/j.neuroscience.2011.09.059. Epub 2011 Oct 1.

Dopaminergic drug-induced modulation of the expression of the dopamine transporter in peripheral blood lymphocytes in Parkinson's disease

Fanciulli A, Misasi R, Campanelli D, Buttarelli FR, Pontieri FR.

Pharmacol Rep. 2011;63(4):1056-60. doi: 10.1016/s1734-1140(11)70622-3.

Personality and social cognition in neurodegenerative disease

Shany-Ur T, Rankin KP.

Curr Opin Neurol. 2011 Dec;24(6):550-5. doi: 10.1097/WCO.0b013e32834cd42a.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias